Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-13,700
Closed -$183K 12603
2023
Q4
$183K Hold
13,700
﹤0.01% 10771
2023
Q3
$199K Hold
13,700
﹤0.01% 10239
2023
Q2
$270K Hold
13,700
﹤0.01% 9655
2023
Q1
$223K Sell
13,700
-30,300
-69% -$468K ﹤0.01% 10359
2022
Q4
$460K Buy
44,000
+41,067
+1,400% +$364K ﹤0.01% 8089
2022
Q3
$16K Buy
2,933
+1,220
+71% +$9.19K ﹤0.01% 12669
2022
Q2
$15K Sell
1,713
-787
-31% -$9.15K ﹤0.01% 12427
2022
Q1
$44K Sell
2,500
-2,467
-50% -$76.8K ﹤0.01% 12359
2021
Q4
$282K Sell
4,967
-14,573
-75% -$973K ﹤0.01% 10633
2021
Q3
$1.47M Buy
19,540
+4,233
+28% +$448K ﹤0.01% 6536
2021
Q2
$2.57M Buy
15,307
+6,827
+81% +$1.2M ﹤0.01% 5356
2021
Q1
$1.49M Buy
+8,480
New +$1.71M ﹤0.01% 6658

Other funds holding GOCO

Jeff Yass's GOCO Position: Q2 2026 in Review

Jeff Yass sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 15,392 shares — an estimated $23.2K sold.

Jeff Yass first reported a position in GOCO in Q3 2020 and held it in 12 quarters. The position peaked at $4.66M in Q1 2021. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • Jeff Yass reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 15,392 GoHealth shares in Q2 2026, an estimated $23.2K.
  • Jeff Yass first reported a position in GoHealth in Q3 2020 and held it in 12 quarters.
  • Jeff Yass's GoHealth position peaked at $4.66M in Q1 2021.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.